Pharmacoeconomics

Bulk Medicine-Buying Program Works For TB, Could Do Same For AIDS Drugs

Published in TB and Outbreaks Week, July 10th, 2001

A World Health Organization program that buys tuberculosis medicines in bulk at competitive prices is working well - with reductions of over 30% - and could serve as a model to help reduce costs of antiretroviral drugs against HIV/AIDS in poor countries.

The New York Times News Service quoted Dr. David L. Heymann, the executive director in charge of communicable diseases for the WHO, as saying of the TB program, "We did not suspect that there would be such price reductions." Before the program, a six-month supply of TB drugs cost WHO between US$15-20. With the market incentive of the program, that cost dropped to about $10, the News Service article said (Price of TB...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of TB and Outbreaks Week

Source: TB and Outbreaks Week (2001-07-10)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry